Bank Julius Baer & Co’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-536
| Closed | -$7K | – | 604 |
|
2022
Q3 | $7K | Sell |
536
-9
| -2% | -$118 | ﹤0.01% | 560 |
|
2022
Q2 | $8K | Hold |
545
| – | – | ﹤0.01% | 587 |
|
2022
Q1 | $9K | Hold |
545
| – | – | ﹤0.01% | 570 |
|
2021
Q4 | $9K | Sell |
545
-270
| -33% | -$4.46K | ﹤0.01% | 790 |
|
2021
Q3 | $12K | Buy |
815
+14
| +2% | +$206 | ﹤0.01% | 771 |
|
2021
Q2 | $16K | Sell |
801
-14
| -2% | -$280 | ﹤0.01% | 772 |
|
2021
Q1 | $19K | Buy |
815
+5
| +0.6% | +$117 | ﹤0.01% | 752 |
|
2020
Q4 | $20K | Sell |
810
-5
| -0.6% | -$123 | ﹤0.01% | 748 |
|
2020
Q3 | $34K | Sell |
815
-530
| -39% | -$22.1K | ﹤0.01% | 635 |
|
2020
Q2 | $64K | Buy |
1,345
+1
| +0.1% | +$48 | ﹤0.01% | 552 |
|
2020
Q1 | $85K | Buy |
+1,344
| New | +$85K | ﹤0.01% | 502 |
|